Seikagaku Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seikagaku with three other
companies in this sector in JAPAN :
Koei Chemical Company, Limited
sales of 18.53 billion Japanese Yen [US$177.13 million]
of which 82%
was Fine Products Division),
Eiken Chemical Co., Ltd.
(36.59 billion Japanese Yen [US$349.75 million]
of which 55%
was Immunoserology Test Agent), and
Nippon Chemiphar Co., Ltd.
(31.76 billion Japanese Yen [US$303.59 million]
of which 96%
was Pharmaceutical Business).
Seikagaku reported sales of ¥28.64 billion (US$273.82 million)
March of 2020.
a very small
increase of 0.9%
versus 2019, when the company's sales were ¥28.38 billion.
Despite this increase, sales are still
below the level achieved in 2018, when Seikagaku
reported sales of ¥30.18 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Seikagaku had sales
of ¥29.52 billion.
Sales of Pharmaceutical Products saw an increase
1.2% in 2020, from
¥21.89 billion to ¥22.17 billion.
Not all segments of Seikagaku experienced an increase in sales in 2020:
sales of Lal fell 0.2% to ¥6.48 billion.